Proud Moment for GENET?KS Global in Precision Medicine!
Genetiks Genetik Hastal?klar De?erlendirme Merkezi
“Nesilden nesile sa?l??? aktarmak i?in ihtiyac?m?z olan bilim: Genetik”
We are delighted to share that our CEO Ahmet Eren SAYIN, was an invited speaker at the Precision Med Exhibition in Dubai on May 8-9. This prestigious event highlighted the latest innovations in precision medicine and attracted over 7,000 health professionals, industry leaders, pioneers, government regulators, and investors from around the world.
His session highlighted our exceptional experience with the OnkoGenetiks? Comprehensive Genomic Profiling (CGP) test, powered by Thermo Fisher Scientific's Oncomine? Comprehensive Assay Plus (OCA Plus).
Here are some key features of our OnkoGenetiks? CGP test:
During his presentation, Ahmet Eren SAYIN highlighted case studies demonstrating how the identification of clinical biomarkers such as TMB, MSI, LOH, HRD, key variants, and fusions can guide clinicians in providing personalized diagnoses and treatments, including tailored immunotherapy solutions.
At GENET?KS GLOBAL, we are dedicated to advancing personalized cancer treatment through next generation genetic diagnostics. Our use of the OCA Plus solution allows us to provide in-depth analysis of tumor tissue samples, offering tailored and targeted treatment options for patients with urgent medical needs such as Breast-Ovarian Cancer, Pancreatic Cancer, Colorectal Cancer, Lung Cancer.
We are excited about the future of personalized medicine and the transformative role advanced molecular profiling will play in patient care.
领英推荐
In addition to Next Generation Oncology, we offer a wide range of comprehensive services, including:
For more details about our services, please visit our website or connect with us on social media.
#GenetiksGlobal #Onkogenetiks #Genetics #Onkology #precissionmedicine #Genomicprofile #cancer #personaltreathment #ThermoFisherScientific #OnkoGenetiksCGP #OCAPlus #geneticdiagnostic #healthinnovation